Izirize Solution for Injection: Inclisiran (284 mg)

Izirize is a sterile, injectable solution of Inclisiran (284mg) for subcutaneous administration. This once-yearly treatment provides long-lasting efficacy for individuals with homozygous familial hypercholesterolemia (HoFH), who experience significantly elevated LDL cholesterol levels.

Izirize utilizes microRNA interference technology to suppress the expression of genes responsible for producing apolipoprotein B, a protein that aids in the absorption of LDL from the bloodstream. This targeted approach helps lower harmful LDL cholesterol, reducing the risk of cardiovascular events in HoFH patients.

Key Features:

* Long-lasting efficacy: One injection per year provides sustained LDL reduction.
* Simple administration: Subcutaneous injection for easy and convenient dosage.
* Targeted treatment: Precisely regulates apolipoprotein B expression to control cholesterol levels.
* Proven safety and effectiveness: Izirize has been extensively studied and demonstrated a significant reduction in LDL cholesterol in clinical trials.

Please note: Izirize is only available with a prescription from a healthcare professional. Always consult your doctor before starting any new medication, including Izirize.